Given the prevalence of ADNP somatic mutations in postmortem AD brains and the potential convergence of identified gene mutations on the cytoskeleton, we hypothesized cytoskeletal damage as a consequence of ADNP mutations. The gene discussed is ADNP; the disease is Alzheimer disease.